A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)

Clinical trial NCT07760818 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07760818
Sponsor: argenx
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sjogrens Disease Primary Sjögren's Syndrome Painful Sensory Neuropathies

Start date: 2026-08-14
Primary completion: 2028-07-28
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.